Latest filing published 14 Oct 2026 for Q32 Bio Inc., €9,639. Read the official filing
This profile gathers the share dealings of Lee Kalowski across 2 companies, led by Q32 Bio Inc. and BICYCLE THERAPEUTICS plc. In total, 15 filings cover trades dated from 29 July 2021 to 6 October 2026.
Sales make up the whole of the open-market record (6 sales, €122k). Other entries cover 5 share grants and 4 option exercises. So far in 2026, the count stands at no purchases and 3 sales.
The record was last updated on 14 October 2026 with an open-market sale (€9,639) in Q32 Bio Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
15 of 15 declarations